CSL Behring Products

CSL Behring Products

Annual Report Contents > Business Features > CSL Behring Feature > CSL Behring Products

Major plasma products marketed by CSL Behring
Haemophilia and Other Coagulation Disorders Coagulation therapies are used to treat bleeding disorders such as Haemophilia and Other Coagulation Disorders. Plasma-derived Factor VIII and von Willebrand Factor Beriate® P Monoclate-P® Humate-P® Haemate® P Recombinant Factor VIII Helixate® FS Helixate® NexGen Plasma-derived Factor IX Berinin® P Mononine® Plasma-derived Factor X Factor X P Other Products Stimate® Octostim® Minirin®	Immune Disorders and Immune Therapy Immunoglobulins are used to treat infections and autoimmune diseases, and to prevent haemolytic disease in the newborn. Polyvalent Immunoglobulins Carimune® NF Redimune® Redimune® NF Liquid Sandoglobulin® Sandoglobulin® NF Liquid Sanglopor® Lymphoglobuline® Subcutaneous Immunoglobulins Vivaglobin® Specific Immunoglobulins Beriglobin® P Berirab® P Hepatitis B Immunoglobulin Rhesogamma® P Rhophylac® Tetagam® P Varicellon® P Cytogam®
Alpha 1-Proteinase Inhibitor Deficiency For people at risk from life-shortening emphysema through a genetic deficiency in their synthesis of this protein. Zemaira® Critical Care Conditions Critical care products are used to treat shock, sepsis and severe burns, and are used in cardiac surgery. Coagulation Disorders Beriplex® P/N Fibrogammin® P Haemocomplettan® P Kybernin® P Trauma Therapies Albuminar® Human Albumin AlbuRx™ Other Critical Care Berinert® P Minirin® Parenteral Innohep® Streptase®	Wound Healing Wound healing therapies are used to facilitate healing. Beriplast® P Fibrogammin® P Tachocomb®